Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial-Reference-Cited by-同舟云学术

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial

Published:1997-11 Issue:5 Volume:37 Page:740-745
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Drake Lynn A.,Shear Neil H.,Arlette Jon P.,Cloutier Richard,Danbye Frederick W.,Elewski Boni E.,Garnis-Jones Sylvia,Giroux Jean-Mario,Gratton David,Gulliver Wayne,Hull Peter,Jones H.Earl,Journet Michel,Krol Alfons L.,Leyden James J.,Maddin Stuart C.,Ross J.Barrie,Savin Ronald C.,Scher Richard K.,Sibbald Gary R.,Tawfik Naji H.,Zaias Nardo,Tolpin Mark,Evans Sandra,Marsolais Christian,Chinv Thomas,Lin Tsuang-Hua,Maher Thomas,Birnbaum Jay E.

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Dermatology

Reference15 articles.

1. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey;Roberts;Br J Dermatol,1992

2. Onychomycosis;André;Int J Dermatol,1987

3. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases;Villars;Br J Dermatol,1992

4. The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine;Zaias;Clin Exp Dermatol,1989

5. Short term treatment of dermatophyte onychomycosis with terbinafine;Goodfield;BMJ,1992

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosis;Expert Opinion on Pharmacotherapy;2024-01-02

2. Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study;British Journal of Dermatology;2023-05-30

3. Onychomycosis;Journal of the Dermatology Nurses' Association;2023-05

4. Novel and Investigational Treatments for Onychomycosis;Journal of Fungi;2022-10-14

5. Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials;Journal of Fungi;2022-03-09